Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
898.00    -10.00 (-1.10%)
Bid:
896.00
Ask:
898.00
Spread: 2.00 (0.223%)
Market Cap: £19.06b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

AIB Group plc - SREP

26 Jan 2022 07:06

RNS Number : 6801Z
AIB Group PLC
26 January 2022
 

 

 

 

26 January 2022

AIB Group plc - SREP

 

 

Supervisory Review and Evaluation Process (SREP)

 

Following the Supervisory Review and Evaluation Process (SREP) performed by the ECB in 2021 and the re-introduction of the UK Countercyclical buffer in December 2022, the minimum requirement for the CET1 ratio for AIB Group plc (AIB) was set at 10.20% for FY 2022 (1) - see table below. The Pillar 2 Requirement reduced by 25bps to 2.75% from 3.00%.

 

AIB continues to have a very strong capital base with a fully loaded CET1 at September 2021 of 16.6%. The Group's reported capital ratios are materially in excess of minimum regulatory requirements and AIB continues to maintain a very significant buffer above maximum distributable amount (MDA) trigger levels.

 

AIB does not disclose Pillar 2 Guidance (P2G), however following the ECB's revised P2G methodology, AIB confirms it is in bucket 3 which has a P2G range of 1.00% - 2.75%.

 

The table below shows the total capital requirements of the Group and components based on an assumption of optimal usage of Tier 2 and AT1 instruments permitted under the Capital Requirements Regulation (CRR).

 

SREP Requirements

AIB SREP Requirement 2021

AIB SREP Requirement 2022

AIB SREP Requirement 2023

 

 

 

 

Pillar 1 CET1

4.50%

4.50%

4.50%

Pillar 2 Requirement (P2R) CET1 (2)

1.69%

1.55%

1.55%

Capital Conservation Buffer (CCB)

2.50%

2.50%

2.50%

Other Systemically Important Institutions Buffer (O-SII)

1.50%

1.50%

1.50%

Countercyclical buffer (CCyB) (3)

0.00%

0.15%

0.35%

Total CET 1 requirement

10.19%

10.20%

10.40%

AT1

2.06%

2.02%

2.02%

Tier 2

2.75%

2.69%

2.69%

Total Capital Requirement (1)

15.00%

14.90%

15.10%

(1) Excludes Pillar 2 Guidance (P2G)

(2) P2R of 2.75% of which 1.55% must be held in the form of CET1 assuming 52bps AT1 and 69bps Tier 2 to meet P2R requirement

(3) Countercyclical buffer - re-introduction of the UK CCyB at 1% in December 2022, rising to 2% in 2023. It is estimated to equate to a Group requirement of c.0.15% in 2022 and c. 0.35% in 2023.

 

     

Figures presented may be subject to rounding

 

For further information, please contact:

Niamh Hore

Siobhain Walsh

Head of Investor Relations

Head of Debt Investor Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6411817

Tel: +353-1-6411901

email: niamh.a.hore@aib.ie

email: siobhain.m.walsh@aib.ie

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEESWMEESESF
Date   Source Headline
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc
27th Jun 20235:09 pmRNSProposed Secondary Placing of Ordinary shares
23rd Jun 20233:27 pmRNSHolding(s) in Company
9th Jun 20233:56 pmRNSHolding(s) in Company
9th Jun 20237:00 amRNSHolding(s) in Company
1st Jun 20232:09 pmRNSHolding(s) in Company
12th May 20235:28 pmRNSHolding(s) in Company
12th May 20231:40 pmRNSDirector/PDMR Shareholding
4th May 20234:50 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20234:17 pmRNSTotal Voting Rights
28th Apr 20239:40 amRNSHolding(s) in Company
25th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20233:16 pmRNSHolding(s) in Company
6th Apr 20232:26 pmRNSHolding(s) in Company
31st Mar 20233:00 pmRNSNotice of AGM
15th Mar 20237:00 amRNSHolding(s) in Company
10th Mar 20235:55 pmRNSDividend Declaration
10th Mar 20232:48 pmRNSHolding(s) in Company
9th Mar 20233:52 pmRNSHolding(s) in Company
8th Mar 20235:12 pmRNSHolding(s) in Company
8th Mar 20237:00 amRNSAnnual Financial Report
21st Feb 20232:06 pmRNSHolding(s) in Company
20th Feb 20232:26 pmRNSHolding(s) in Company
17th Feb 20235:44 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHolding(s) in Company
17th Jan 20239:20 amRNSStabilisation Notice
16th Jan 20239:48 amRNSStabilisation Notice
13th Jan 202312:15 pmRNSAIB - CCPC clearance tracker mortgages acquisition
6th Jan 20237:00 amRNSExtension of the AIB Group Plc Share Trading Plan
5th Dec 20223:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.